局限性前列腺癌的定量PSMA-PET参数:预后及潜在预测价值
本单中心回顾性分析纳入86例局限性中危或高危前列腺癌患者,治疗前接受PSMA-PET,评估SUVmax、肿瘤非球面度(ASP)、PSMA肿瘤体积(PSMA-TV)和PSMA总病灶摄取(PSMA-TLU)的预后意义。全队列中PSMA-TV(p=0.003)、PSMA-TLU(p=0.004)和ASP(p<0.001)与总生存显著相关;高危手术患者中SUVmax截断值8.6与局部区域控制显著相关(p=0.048),但原发性放疗患者中无此关联(p=0.34)。
要点
- 全队列中PSMA-TV、PSMA-TLU和ASP与总生存显著相关。
- 高危手术患者中SUVmax截断值8.6与局部区域控制显著相关(p=0.048)。
- PSMA-TLU(p=0.016)似乎是有前景的手术患者分层生物标志物。
核心结论
- 数据证实既往关于SUVmax在高危前列腺癌手术患者中预后影响的发表结果。
- 探索性分析提示PSMA-TLU可能更合适。
- 与原发性放疗患者缺乏关联,需更大样本前瞻性验证以得出预测潜力。
研究设计与样本
- 单中心回顾性分析,纳入86例连续局限性中危或高危前列腺癌患者,治疗前接受PSMA-PET。
- 评估定量PET参数SUVmax、ASP、PSMA-TV和PSMA-TLU(PSMA-TV×SUVmean)在放疗或手术患者中的预后意义。
- 对生化无复发生存、总生存、局部控制和局部区域控制进行Cox回归分析。
主要发现
- 67%患者为高危疾病,51例接受放疗,35例接受手术。
- 全队列中PSMA-TV(p=0.003)、PSMA-TLU(p=0.004)和ASP(p<0.001)与总生存显著相关。
- PET参数二值化后,多个其他参数与临床结局显著相关。
- 高危手术患者中SUVmax截断值8.6与局部区域控制显著相关(p=0.048),原发性放疗患者中无显著关联(p=0.34)。
- 手术患者中PSMA-TLU(p=0.016)似乎是有前景的分层生物标志物。
关键数值与推荐
- 全队列中PSMA-TV与总生存显著相关(p=0.003)。
- 全队列中PSMA-TLU与总生存显著相关(p=0.004)。
- 全队列中ASP与总生存显著相关(p<0.001)。
- 高危手术患者中SUVmax截断值8.6与局部区域控制显著相关(p=0.048)。
- 高危原发性放疗患者中SUVmax截断值8.6与局部区域控制无显著关联(p=0.34)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究为回顾性研究,未进行注册。
- 与原发性放疗患者缺乏关联,需更大样本前瞻性验证以得出预测潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: PSMA-PET is increasingly used for staging prostate cancer (PCA) patients. However, it is not clear if quantitative imaging parameters of positron emission tomography (PET) have an impact on disease progression and are thus important for the prognosis of localized PCA. METHODS: This is a monocenter retrospective analysis of 86 consecutive patients with localized intermediate or high-risk PCA and PSMA-PET before treatment The quantitative PET parameters maximum standardized uptake value (SUVmax), tumor asphericity (ASP), PSMA tumor volume (PSMA-TV), and PSMA total lesion uptake (PSMA-TLU = PSMA-TV × SUVmean) were assessed for their prognostic significance in patients with radiotherapy or surgery. Cox regression analyses were performed for biochemical recurrence-free survival, overall survival (OS), local control, and loco-regional control (LRC). RESULTS: 67% of patients had high-risk disease, 51 patients were treated with radiotherapy, and 35 with surgery. Analysis of metric PET parameters in the whole cohort revealed a significant association of PSMA-TV (p = 0.003), PSMA-TLU (p = 0.004), and ASP (p < 0.001) with OS. Upon binarization of PET parameters, several other parameters showed a significant association with clinical outcome. When analyzing high-risk patients according to the primary treatment approach, a previously published cut-off for SUVmax (8.6) showed a significant association with LRC in surgically treated (p = 0.048), but not in primary irradiated (p = 0.34) patients. In addition, PSMA-TLU (p = 0.016) seemed to be a very promising biomarker to stratify surgical patients. CONCLUSION: Our data confirm one previous publication on the prognostic impact of SUVmax in surgically treated patients with high-risk PCA. Our exploratory analysis indicates that PSMA-TLU might be even better suited. The missing association with primary irradiated patients needs prospective validation with a larger sample size to conclude a predictive potential. Trial registration Due to the retrospective nature of this research, no registration was carried out.
引用
- Bela Andela S, Amthauer H, Furth C, et al. Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value. Radiat Oncol. 2024. PMID: 39080696. doi:10.1186/s13014-024-02483-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。